Not Signed In - Evotec Initiates Phase II Clinical Trial With EVT 201 For The Treatment Of Insomnia
Fri, 22 Sep 2006 07:00 AM EST
... Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX 30, "Evotec") announced today the initiation of a Phase II clinical trial with EVT 201 for the treatment of insomnia under a US IND. This US, multi-centre, double-blind trial is designed to evaluate the efficacy of EVT 201 in a three way cross-over design in 66 patients with primary insomnia. [click link for full article] ...
Related Topics
- Clinical Trials
- Insomnia
- Thallium
- Pharmacology
- Pancreatic Cancer
- Trastuzumab
- Psychopharmacology
- Crohn's Disease
- Tarceva
- Nystatin and Triamcinolone
- Food Recommendations: South Beach Diet - Phase 1
- Food Recommendations: South Beach Diet - Phase 2
- Depression
- Western/Clinical Treatment and Therapy
- Bevacizumab Injection
- Clinical Growth Charts
- Juvenile Diabetes
- Ovarian Cancer
- Hypersomnia
- Bipolar Disorder
email this page
print this page
bookmark this page
feedback on this page
